Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PROSECO - A UK Multicentre Prospective Observational Study Evaluating COVID-19 Vaccine Immune Responses in Lymphoid Cancer

NCT04858568 is registered in ClinicalTrials.gov with University Hospital Southampton NHS Foundation Trust as lead sponsor.

NCT NCT04858568
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04858568 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PROSECO - A UK Multicentre Prospective Observational Study Evaluating COVID-19 Vaccine Immune Responses in Lymphoid Cancer
Lead sponsor
University Hospital Southampton NHS Foundation Trust
Phase
Observational
Overall status
Completed
Start date
March 11, 2021
Completion date
January 31, 2024
Enrollment
592 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

burkitt lymphoma, chronic lymphocytic leukemia, classical hodgkin lymphoma, diffuse large b cell lymphoma, follicular lymphoma, high-grade b-cell lymphoma, lymphoplasmacytic lymphoma, mantle cell lymphoma, marginal zone lymphoma, nodular lymphocyte predominant hodgkin lymphoma, peripheral t-cell lymphoma, primary mediastinal b cell lymphoma, small lymphocytic lymphoma